These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 12373630

  • 1. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
    Palermo M, Armanini D, Shackleton CH, Sorba G, Cossu M, Roitman E, Scaroni C, Delitala G.
    Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):272-6. PubMed ID: 12373630
    [Abstract] [Full Text] [Related]

  • 2. Apparent mineralocorticoid excess.
    Benediktsson R, Edwards CR.
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [Abstract] [Full Text] [Related]

  • 3. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
    Heilmann P, Heide J, Hundertmark S, Schöneshöfer M.
    Exp Clin Endocrinol Diabetes; 1999 May; 107(6):370-8. PubMed ID: 10543414
    [Abstract] [Full Text] [Related]

  • 4. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 5. Apparent mineralocorticoid excess.
    Funder JW.
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [Abstract] [Full Text] [Related]

  • 6. Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase.
    Lee YS, Lorenzo BJ, Koufis T, Reidenberg MM.
    Clin Pharmacol Ther; 1996 Jan; 59(1):62-71. PubMed ID: 8549035
    [Abstract] [Full Text] [Related]

  • 7. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, Kanazawa M, Miwa T, Notoya Y, Niitsuma T, Hayashi T.
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [Abstract] [Full Text] [Related]

  • 8. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 9. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Jul; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 10. Apparent mineralocorticoid excess syndromes.
    Shimojo M, Stewart PM.
    J Endocrinol Invest; 1995 Jul; 18(7):518-32. PubMed ID: 9221270
    [Abstract] [Full Text] [Related]

  • 11. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
    Bonvalet JP, Doignon I, Blot-Chabaud M, Pradelles P, Farman N.
    J Clin Invest; 1990 Sep; 86(3):832-7. PubMed ID: 2394832
    [Abstract] [Full Text] [Related]

  • 12. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH.
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [Abstract] [Full Text] [Related]

  • 13. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [Abstract] [Full Text] [Related]

  • 14. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L, Carvajal C, Campino C, Rojas A, González A, Barraza A, Montero J, Fardella C.
    Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
    [Abstract] [Full Text] [Related]

  • 15. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 16. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 17. Cortisol metabolism in the postoperative period after cardiac surgery.
    Vogeser M, Felbinger TW, Röll W, Jacob K.
    Exp Clin Endocrinol Diabetes; 1999 Nov; 107(8):539-46. PubMed ID: 10612485
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
    Sewell KJ, Shirley DG, Michael AE, Thompson A, Norgate DP, Unwin RJ.
    Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
    [Abstract] [Full Text] [Related]

  • 19. [From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids].
    Levtchenko EN, Deinum J, Knoers NV, Hermus AR, Monnens LA, Lenders JW.
    Ned Tijdschr Geneeskd; 2007 Mar 24; 151(12):692-4. PubMed ID: 17447595
    [Abstract] [Full Text] [Related]

  • 20. Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics.
    Santini DL, Lorenzo BJ, Koufis T, Reidenberg MM.
    Am J Hypertens; 1995 May 24; 8(5 Pt 1):516-9. PubMed ID: 7662229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.